General Information

Stock Quote

ABMD (Common Stock)
Exchange NASDAQ (US Dollar)
Price   $52.33
Change (%)   Stock is Up  0.08  (0.15%)
Volume   292,600
Data as of 01/30/15 1:12 PM ET
Minimum 20 minute delay
Refresh quote

Corporate Profile

Abiomed (NASDAQ: ABMD) is a global technology leader focused on RECOVERING HEARTS AND SAVING LIVES.

Abiomed CEO, Chairman, and President, Michael R. Minogue, has focused the company’s efforts on developing ground-breaking technologies designed to assist or replace the life-sustaining pumping function of the failing heart. The Company’s portfolio of products and services offer healthcare professionals an array of choices across a broad clinical spectrum. From the world’s first total replacement heart to the World’s Smallest Heart Pump, 1/100th the size of the heart with rapid and simple insertion, Abiomed is dedicated to finding ways to bring the most advanced and beneficial technology to patients and physicians.

More>>

More »   Recent News

Date Title  
01/27/15

DANVERS, Mass., Jan. 27, 2015 (GLOBE NEWSWIRE) -- Abiomed Inc. (Nasdaq:ABMD), a leading provider of breakthrough heart support technologies, today announced that the Impella RP® (Right Percutaneous) System has received U.S. Food and Drug Administration (FDA) approval under a Humanitarian Device Exemption (HDE). This innovative medical device i...

01/27/15

DANVERS, Mass., Jan. 27, 2015 (GLOBE NEWSWIRE) -- Abiomed, Inc. (Nasdaq:ABMD), a leading provider of breakthrough heart support technologies, today reported third quarter fiscal 2015 revenue of $62.0 million, up 34% compared to revenue of $46.2 million in the same period of fiscal 2014, and a third quarter fiscal 2015 GAAP net income of $12.7 milli...

01/26/15

DANVERS, Mass., Jan. 26, 2015 (GLOBE NEWSWIRE) -- In response to the state of emergency declared in Massachusetts due to the impending winter storm tomorrow, Abiomed, Inc. (Nasdaq:ABMD) is announcing that it will reschedule its third quarter fiscal 2015 earnings release and conference call. The call, originally scheduled for Tuesday, January 27...

01/06/15

DANVERS, Mass., Jan. 6, 2015 (GLOBE NEWSWIRE) -- Abiomed, Inc. (Nasdaq:ABMD) announced today that on Tuesday, January 27, 2015, the Company will release financial results for the third quarter of fiscal 2015. The Company will host a conference call to discuss the results on Tuesday, January 27, 2015, at 8:00 a.m. EST. Michael R. Minogue, Chairman, ...

11/26/14

DANVERS, Mass., Nov. 26, 2014 (GLOBE NEWSWIRE) -- Abiomed, Inc. (Nasdaq:ABMD), a leading provider of breakthrough heart support technologies, today announced that Robert L. Bowen Vice President & Chief Financial Officer, will present at the Piper Jaffray 26th Annual Healthcare Conference on December 3, 2014 at 12:00 p.m. EST. The conference will be...